About
Peptide drugs
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyVirginia, DC, DE & Maryland
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
213
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT02367924Lead Sponsor
Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma
N/ACompleted
130 participants
Started: Jul 16, 2015 · Completed: Dec 31, 2020
NCT01869400Lead Sponsor
An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer
N/ACompleted
83 participants
Started: Apr 30, 2013 · Completed: Feb 28, 2017
Locations (1)
Headquarters
Manassas, VA, United States
Map
Loading map...